Evidence of homosubtypic but not heterosubtypic immunity in young children following wild-type influenza illness

Pediatric Infectious Disease Journal

Volumn 30, Issue 10, 2011, Pages 900-901

  Ambrose, Christopher S ^a   Wu, Xionghua ^a  

^a MEDIMMUNE   (United States)

Author keywords

children; heterosubtypic; heterotypic; homosubtypic; influenza

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; DRUG EFFICACY; HETEROSUBTYPIC IMMUNITY; HOMOSUBTYPIC IMMUNITY; HUMAN; IMMUNITY; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; PRIORITY JOURNAL; VACCINATION; WILD TYPE;

EID: 80052932690     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31821ffe43     Document Type: Article

References (10)

1. Grebe KM, Yewdell JW, Bennink JR. Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect. 2008;10:1024-1029.
2. Bodewes R, Kreijtz JH, Baas C, et al. Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS One. 2009;4:e5538.
3. Epstein SL. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis. 2006;193:49-53. (Pubitemid 43032498)
4. Slepushkin AN. The effect of a previous attack of A1 influenza on susceptibility to A2 virus during the 1957 outbreak. Bull World Health Organ. 1959;20:297-301.
5. Sonoguchi T, Naito H, Hara M, et al. Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis. 1985;151:81-88. (Pubitemid 15192884)
6. Steinhoff MC, Fries LF, Karron RA, et al. Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children. J Clin Microbiol. 1993;31:836-838. (Pubitemid 23086524)
7. Vesikari T, Fleming DM, Aristegui JF, et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics. 2006;118:2298-2312. (Pubitemid 46397567)
8. Tam JS, Capeding MR, Lum LC, et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J. 2007;26:619-628. (Pubitemid 47014164)
9. Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr. 2000;136:168-175. (Pubitemid 30470986)
10. Bracco Neto H, Farhat CK, Tregnaghi MW, et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Pediatr Infect Dis J. 2009;28:365-371.